Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)
UCB Biopharma SRL
Iain B McInnes; Akihiko Asahina; Laura C Coates; Robert Landewé; Joseph F Merola; Christopher T Ritchlin; Yoshiya Tanaka; Laure Gossec; Alice B Gottlieb; Richard B Warren; Barbara Ink; Deepak Assudani; Rajan Bajracharya; Vishvesh Shende; Jason Coarse; Philip J Mease